The Dark Side of Protein Kinase CK2 Inhibition

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|19|2867-2884

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.19, 2011-06, pp. : 2867-2884

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Kinase CK2 Inhibition: An Update

By  

Current Medicinal Chemistry, Vol. 20, Iss. 5, 2013-02 ,pp. : 671-693

Bentham Science Publishers

Access to resources Recommend Favorite

Protein kinase CK2 inhibitors: a patent review

By Cozza Giorgio   Pinna Lorenzo A   Moro Stefano  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 9, 2012-09 ,pp. : 1081-1097

Informa Healthcare

Access to resources Recommend Favorite

Protein Kinase CK2 in Human Diseases

By  

Current Medicinal Chemistry, Vol. 15, Iss. 19, 2008-01 ,pp. : 1870-1886

Bentham Science Publishers

Access to resources Recommend Favorite

Protein Kinase CK2 as Regulator of Cell Survival: Implications for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 4, Iss. 1, 2004-02 ,pp. : 77-84

Bentham Science Publishers

Access to resources Recommend Favorite

ATP Site-Directed Inhibitors of Protein Kinase CK2: An Update

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 11, 2011-06 ,pp. : 1340-1351

Bentham Science Publishers

Access to resources Recommend Favorite